Latest Financials News

Clever Culture Systems reports a cashflow positive quarter, expanding its pharmaceutical customer base and launching a new contact plate analysis module that promises to drive recurring revenues.

Conico Ltd updates shareholders on a significant capital raising expansion, including a share consolidation and converting loan conversions to fund exploration at Mount Thirsty.

BluGlass Limited reports a robust project pipeline exceeding US$100 million, bolstered by initial orders from Collins Aerospace and Infleqtion Inc, alongside strategic board appointments and a $6 million R&D tax rebate.

Advance Metals has significantly expanded its precious metals footprint with the Guadalupe y Calvo acquisition, maiden drilling success at Yoquivo, and completion of the Gavilanes deal, backed by a $13 million capital raise.

Pantera Lithium Limited has secured a significant 5,000-acre exploration footprint in Southwest Arkansas, targeting antimony and silver in a historically rich but long-neglected mining district. This move aligns with U.S. critical minerals priorities and leverages Pantera’s proven local expertise.

Aurora Labs has advanced its micro gas turbine propulsion program with critical durability testing, a new Defence contract phase, and a strategic $5.5 million capital raise to scale manufacturing and commercialisation.

Encounter Resources has raised A$25 million through an institutional placement to fast-track its Aileron niobium-REE project and expand copper exploration across Western Australia and the Northern Territory.

Arovella Therapeutics reported solid progress in Q1 FY26, moving closer to initiating its first-in-human trial for ALA-101 while securing key patents and maintaining a strong cash position.

Norwest Minerals advances its Bulgera Gold Project with successful deep drilling and promising heap leach economics, while preparing to test historic gold targets at Marymia East and expanding base metals exploration at Arunta West.

Way2VAT Ltd has completed its acquisition of RBC VAT Limited, boosting its European footprint and advisory services, while reporting a record quarterly revenue of A$1.89 million, up 34% year-on-year.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Australian Dairy Nutritionals reported a 66% year-on-year revenue increase in Q1 FY26, driven by strong nutritional powder sales and expanded distribution in China, while improving cash flow and production capacity.